Close Menu

NEW YORK (GenomeWeb) — InDevR said today that it has received 510(k) clearance from the US Food and Drug Administration for its FluChip-8G Influenza A+B assay.

The RT-PCR-based in vitro diagnostic is designed to detect whole gene segments for influenza A and B viruses in order to identify and differentiate them. A machine learning algorithm then identifies the signal pattern of specific target virus groups to help characterize infections as seasonal or nonseasonal.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.